← Back to Clinical Trials
Recruiting NCT07307703

NCT07307703 TENS for Anxiety, Pain, and Satisfaction After Laparoscopic Cholecystectomy

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07307703
Status Recruiting
Phase
Sponsor Nigde Omer Halisdemir University
Condition Gallstone Disease
Study Type INTERVENTIONAL
Enrollment 80 participants
Start Date 2025-12-01
Primary Completion 2026-06-30

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Transcutaneous Electrical Nerve Stimulation (TENS)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 80 participants in total. It began in 2025-12-01 with a primary completion date of 2026-06-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study is designed to evaluate whether Transcutaneous Electrical Nerve Stimulation (TENS) can improve recovery for patients undergoing laparoscopic gallbladder removal surgery (laparoscopic cholecystectomy). TENS is a non-invasive method that uses mild electrical currents applied through the skin to stimulate nerves. The main goals of the study are to determine if TENS can: Reduce surgical anxiety before and during the procedure Decrease postoperative pain after surgery Improve overall patient satisfaction with their surgical experience Patients who participate will receive standard surgical care, and some will also receive TENS therapy. Outcomes will be measured using patient questionnaires and clinical assessments during the hospital stay and follow-up period. By comparing patients who receive TENS with those who do not, the study aims to provide evidence on whether this simple technique can enhance comfort and recovery after gallbladder surgery.

Eligibility Criteria

Inclusion Criteria: * Adults aged 18-65 years scheduled for elective laparoscopic cholecystectomy ASA (American Society of Anesthesiologists) physical status classification I-II Ability to understand the study procedures and provide written informed consent No contraindications to TENS application (e.g., intact skin at electrode placement sites) Willingness to comply with perioperative assessments (pain, anxiety, satisfaction scales) Exclusion Criteria: * Patients with ASA III or higher physical status Presence of cardiac pacemaker or other implanted electrical devices History of epilepsy, severe neuropathy, or psychiatric disorders affecting pain/anxiety perception Skin lesions, infections, or dermatological conditions at electrode placement sites Use of analgesics, anxiolytics, or sedatives beyond standard perioperative protocols Emergency cholecystectomy or conversion to open surgery Pregnant or breastfeeding women Patients unwilling or unable to provide informed consent

Contact & Investigator

Central Contact

Kezban Koraş SÖZEN, Associate Professor

✉ kezbankoras@ohu.edu.tr

📞 +90, 0543 805 62 09

Frequently Asked Questions

Who can join the NCT07307703 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Gallstone Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07307703 currently recruiting?

Yes, NCT07307703 is actively recruiting participants. Contact the research team at kezbankoras@ohu.edu.tr for enrollment information.

Where is the NCT07307703 trial being conducted?

This trial is being conducted at Niğde, Turkey (Türkiye).

Who is sponsoring the NCT07307703 clinical trial?

NCT07307703 is sponsored by Nigde Omer Halisdemir University. The trial plans to enroll 80 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology